Sectors

LEXX
Lexaria Bioscience Corp.
2.99
5 x 3.05
1 x 3.36
bid
ask
+
0.17
6.03%
3 @ 07:27 AM
3.20 +0.21 (7.02%)
Ytd-67.71%
1y-75.85%
2.74
day range
3.11
2.43
52 week range
21.60
Open2.74Prev Close2.82Low2.74High3.11Mkt Cap6.30M
Vol32.49KAvg Vol70.68KEPS-5.10P/EN/AForward P/E-5.64
Beta0.61Short Ratio2.34Inst. Own6.08%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-1450-d Avg6.45200-d Avg9.391yr Est10.00
Income Statement
Operating Expenses1.99M
Research and Development Expense970.83K
Selling, General and Administrative Expense1.02M
Operating Income-1.99M
Income Tax Expense14.00
Net Income-1.99M
Net Income Common Stock-1.99M
Net Income Common Stock (USD)-1.99M
Consolidated Income-1.99M
Net Income to Non-Controlling Interests-1.78K
Earnings per Basic Share-1.20
Earnings per Basic Share (USD)-1.20
Earnings per Diluted Share-1.20
Earning Before Interest & Taxes (EBIT)-1.99M
Earning Before Interest & Taxes (USD)-1.99M
Weighted Average Shares1.65M
Weighted Average Shares Diluted1.65M
Balance Sheet
Cash and Equivalents3.48M
Cash and Equivalents (USD)3.48M
Investments142.10K
Investments Current142.10K
Trade and Non-Trade Receivables113.01K
Current Assets4.06M
Property, Plant & Equipment Net313.43K
Total Assets4.78M
Debt Current33.03K
Total Debt86.71K
Current Liabilities383.41K
Debt Non-Current53.68K
Total Liabilities437.09K
Accumulated Retained Earnings (Deficit)-68.50M
Accumulated Other Comprehensive Income-46.47K
Shareholders Equity4.74M
Shareholders Equity (USD)4.74M
Assets Non-Current716.46K
Total Debt (USD)86.71K
Goodwill and Intangible Assets339.02K
Liabilities Non-Current53.68K
Trade and Non-Trade Payables350.38K
Cash Flow
Depreciation, Amortization & Accretion28.48K
Net Cash Flow / Change in Cash & Cash Equivalents-1.65M
Net Cash Flow from Investing-27.09K
Net Cash Flow - Investment Acquisitions and Disposals-837.00
Net Cash Flow from Operations-1.64M
Effect of Exchange Rate Changes on Cash 8.97K
Share Based Compensation92.94K